Bacterial topoisomerase I as a target for discovery of antibacterial compounds

Nucleic Acids Research

Volumn 37, Issue 3, 2009, Pages 731-737

  Tse Dinh, Yuk Ching ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BACTERIAL DNA; CARDIOLIPIN; CIPROFLOXACIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE INHIBITOR; EXODEOXYRIBONUCLEASE V; INTEGRASE; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; PROTEIN BAD; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RALTEGRAVIR; RECA PROTEIN; RECQ HELICASE; RIBONUCLEASE H; RNA POLYMERASE; ANTIINFECTIVE AGENT; ENZYME INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BACTERIAL CELL; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; CELL DEATH; CELLULAR STRESS RESPONSE; DNA CLEAVAGE; DNA DAMAGE; DNA PROTEIN COMPLEX; DNA REPAIR; DNA SUPERCOILING; DNA TRANSCRIPTION; DRUG TARGETING; ENZYME ACTIVE SITE; ESCHERICHIA COLI; GENE MUTATION; HELICOBACTER PYLORI; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; YERSINIA PESTIS; BACTERIUM; CHEMISTRY; DRUG ANTAGONISM; DRUG DEVELOPMENT; GENETICS; MUTATION; PATHOGENICITY; PHYSIOLOGICAL STRESS; REVIEW;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; YERSINIA PESTIS;

ANTI-BACTERIAL AGENTS; BACTERIA; CELL DEATH; DNA TOPOISOMERASES, TYPE I, BACTERIAL; DRUG DISCOVERY; ENZYME INHIBITORS; MUTATION; STRESS, PHYSIOLOGICAL;

EID: 63349088873     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn936     Document Type: Article

References (85)

1. Wang,J.C. (2002) Cellular roles of DNA topoisomerases: A molecular perspective. Nat. Rev. Mol. Cell Biol., 3, 430-440.
2. Champoux,J.J. (2001) DNA topoisomerases: Structure, function, and mechanism. Annu. Rev. Biochem., 70, 369-413.
3. Corbett,K.D. and Berger,J.M. (2004) Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases. Annu. Rev. Biophys. Biomol. Struct., 33, 95-118.
4. Schoeffler,A.J. and Berger,J.M. (2008) DNA topoisomerases: Harnessing and constraining energy to govern chromosome topology. Q. Rev. Biophys., 41, 41-101.
5. Pommier,Y. (2006) Topoisomerase I inhibitors: Camptothecins and beyond. Nat. Rev. Cancer., 6, 789-802.
6. Maxwell,A. (1999) DNA gyrase as a drug target. Biochem. Soc. Trans. 27, 48-53.
7. Giles,G.I. and Sharma,R.P. (2005) Topoisomerase enzymes as therapeutic targets for cancer chemotherapy. Med. Chem., 1, 383-394.
8. Drlica,K. and Malik,M. (2003) Fluoroquinolones: Action and resistance. Curr. Top. Med. Chem., 3, 249-282.
9. Nitiss,J.L. (2002) DNA topoisomerases in cancer chemotherapy: Using enzymes to generate selective DNA damage. Curr. Opin. Investig Drugs 3, 1512-1516.
10. Liu,L.F. (1989) DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem., 58, 351-375.
11. Drlica,K., Malik,M., Kerns,R.J. and Zhao,X. (2008) Quinolone-mediated bacterial death. Antimicrob. Agents Chemother., 52, 385-392.
12. Forterre,P., Gribaldo,S., Gadelle,D. and Serre,M.C. (2007) Origin and evolution of DNA topoisomerases. Biochimie, 89, 427-446.
13. Viard,T. and de la Tour,C.B. (2007) Type IA topoisomerases: A simple puzzle? Biochimie, 89, 456-467.
14. Menzel,R. and Gellert,M. (1983) Regulation of the genes for E. coli DNA gyrase: Homeostatic control of DNA supercoiling. Cell, 34, 105-113.
15. Tse-Dinh,Y.C. (1985) Regulation of the escherichia coli DNA topoisomerase I gene by DNA supercoiling. Nucleic Acids Res., 13, 4751-4763.
16. Lopez,C.R., Yang,S., Deibler,R.W., Ray,S.A., Pennington,J.M., Digate,R.J., Hastings,P.J., Rosenberg,S.M. and Zechiedrich,E.L. (2005) A role for topoisomerase III in a recombination pathway alternative to RuvABC. Mol. Microbiol., 58, 80-101.
17. DiNardo,S., Voelkel,K.A., Sternglanz,R., Reynolds,A.E. and Wright,A. (1982) Escherichia coli DNA topoisomerase I mutants have compensatory mutations in DNA gyrase genes. Cell, 31, 43-51.
18. Pruss,G.J., Manes,S.H. and Drlica,K. (1982) Escherichia coli DNA topoisomerase I mutants: Increased supercoiling is corrected by mutations near gyrase genes. Cell, 31, 35-42.
19. Richardson,S.M., Higgins,C.F. and Lilley,D.M. (1984) The genetic control of DNA supercoiling in salmonella typhimurium. EMBO J., 3, 1745-1752.
20. Bhriain,N.N. and Dorman,C.J. (1993) Isolation and characterization of a topA mutant of shigella flexneri. Mol. Microbiol., 7, 351-358.
21. Suerbaum,S., Brauer-Steppkes,T., Labigne,A., Cameron,B. and Drlica,K. (1998) Topoisomerase I of helicobacter pylori: Juxtaposition with a flagellin gene (flaB) and functional requirement of a fourth zinc finger motif. Gene, 210, 151-161.
22. Sassetti,C.M. and Rubin,E.J. (2003) Genetic requirements for mycobacterial survival during infection. Proc. Natl Acad. Sci. USA 100, 12989-12994.
23. Zhu,Q., Pongpech,P. and DiGate,R.J. (2001) Type I topoisomerase activity is required for proper chromosomal segregation in escherichia coli. Proc. Natl Acad. Sci. USA, 98, 9766-9771.
24. Stupina,V.A. and Wang,J.C. (2005) Viability of escherichia coli topA mutants lacking DNA topoisomerase I. J. Biol. Chem., 280, 355-360.
25. Masse,E. and Drolet,M. (1999) R-loop-dependent hypernegative supercoiling in escherichia coli topA mutants preferentially occurs at low temperatures and correlates with growth inhibition. J. Mol. Biol. 294, 321-332.
26. Liu,L.F. and Wang,J.C. (1987) Supercoiling of the DNA template during transcription. Proc. Natl Acad. Sci. USA., 84, 7024-7027.
27. Drolet,M. (2006) Growth inhibition mediated by excess negative supercoiling: The interplay between transcription elongation, R-loop formation and DNA topology. Mol. Microbiol., 59, 723-730.
28. Masse,E. and Drolet,M. (1999) Relaxation of transcription-induced negative supercoiling is an essential function of escherichia coli DNA topoisomerase I. J. Biol. Chem., 274, 16654-16658.
29. Cheng,B., Zhu,C.X., Ji,C., Ahumada,A. and Tse-Dinh,Y.C. (2003) Direct interaction between escherichia coli RNA polymerase and the zinc ribbon domains of DNA topoisomerase I. J. Biol. Chem., 278, 30705-30710.
30. Butland,G., Peregrin-Alvarez,J.M., Li,J., Yang,W., Yang,X., Canadien,V., Starostine,A., Richards,D., Beattie,B., Krogan,N. et al. (2005) Interaction network containing conserved and essential protein complexes in escherichia coli. Nature, 433, 531-537.
31. Rui,S. and Tse-Dinh,Y.C. (2003) Topoisomerase function during bacterial responses to environmental challenge. Front. Biosci., 8, D256-D263.
32. Lesley,S.A., Jovanovich,S.B., Tse-Dinh,Y.C. and Burgess,R.R. (1990) Identification of a heat shock promoter in the topA gene of escherichia coli. J. Bacteriol., 172, 6871-6874.
33. Qi,H., Menzel,R. and Tse-Dinh,Y.C. (1997) Regulation of escherichia coli topA gene transcription: Involvement of a sigmaS-dependent promoter. J. Mol. Biol., 267, 481-489.
34. Weinstein-Fischer,D. and Altuvia,S. (2007) Differential regulation of escherichia coli topoisomerase I by fis. Mol. Microbiol., 63 1131-1144.
35. Qi,H., Menzel,R. and Tse-Dinh,Y.C. (1996) Effect of the deletion of the sigma 32-dependent promoter (P1) of the escherichia coli topoisomerase I gene on thermotolerance. Mol. Microbiol., 21, 703-711.
36. Qi,H., Menzel,R. and Tse-Dinh,Y.C. (1999) Increased thermosensitivity associated with topoisomerase I deletion and promoter mutations in escherichia coli. FEMS Microbiol. Lett., 178, 141-146.
37. Tse-Dinh,Y.C. (2000) Increased sensitivity to oxidative challenges associated with topA deletion in escherichia coli. J. Bacteriol., 182, 829-832.
38. Weinstein-Fischer,D., Elgrably-Weiss,M. and Altuvia,S. (2000) Escherichia coli response to hydrogen peroxide: A role for DNA supercoiling, topoisomerase I and fis. Mol. Microbiol., 35, 1413-1420.
39. Dong,Q., Hyde,D., Herra,C., Kean,C., Murphy,P., O'Morain,C.A. and Buckley,M. (2001) Identification of genes regulated by prolonged acid exposure in helicobacter pylori. FEMS Microbiol. Lett., 196, 245-249.
40. Stewart,N., Feng,J., Liu,X., Chaudhuri,D., Foster,J.W., Drolet,M. and Tse-Dinh,Y.C. (2005) Loss of topoisomerase I function affects the RpoS-dependent and GAD systems of acid resistance in escherichia coli. Microbiol., 151, 2783-2791.
41. Huo,Y.X., Rosenthal,A.Z. and Gralla,J.D. (2008) General stress response signalling: Unwrapping transcription complexes by DNA relaxation via the sigma38 C-terminal domain. Mol. Microbiol, 70, 369-378.
42. Gmuender,H., Kuratli,K., Di Padova,K., Gray,C.P., Keck,W. and Evers,S. (2001) Gene expression changes triggered by exposure of haemophilus influenzae to novobiocin or ciprofloxacin: Combined transcription and translation analysis. Genome Res., 11, 28-42.
43. Peter,B.J., Arsuaga,J., Breier,A.M., Khodursky,A.B., Brown,P.O. and Cozzarelli,N.R. (2004) Genomic transcriptional response to loss of chromosomal supercoiling in escherichia coli. Genome Biol., 5 R87.
44. Tessier,M.C., Graveline,R., Crost,C., Desabrais,J.A., Martin,C., Drolet,M. and Harel,J. (2007) Effects of DNA supercoiling and topoisomerases on the expression of genes coding for F165(1), a P-like fimbriae. FEMS Microbiol. Lett., 277, 28-36.
45. Galan,J.E. and Curtiss,R. 3rd. (1990) Expression of salmonella typhimurium genes required for invasion is regulated by changes in DNA supercoiling. Infect. Immun., 58, 1879-1885.
46. Darwin,A.J. and Miller,V.L. (1999) Identification of yersinia enterocolitica genes affecting survival in an animal host using signature-tagged transposon mutagenesis. Mol. Microbiol., 32 51-62.
47. Dozois,C.M., Daigle,F. and Curtiss,R. 3rd. (2003) Identification of pathogen-specific and conserved genes expressed in vivo by an avian pathogenic escherichia coli strain. Proc. Natl Acad. Sci. USA, 100, 247-252.
48. Goswami,M., Mangoli,S.H. and Jawali,N. (2006) Involvement of reactive oxygen species in the action of ciprofloxacin against escherichia coli. Antimicrob. Agents Chemother., 50, 949-954.
49. Dwyer,D.J., Kohanski,M.A., Hayete,B. and Collins,J.J. (2007) Gyrase inhibitors induce an oxidative damage cellular death pathway in escherichia coli. Mol. Syst. Biol., 3, 91.
50. Kohanski,M.A., Dwyer,D.J., Hayete,B., Lawrence,C.A. and Collins,J.J. (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell, 130, 797-810.
51. Phillips,I., Culebras,E., Moreno,F. and Baquero,F. (1987) Induction of the SOS response by new 4-quinolones. J. Antimicrob. Chemother., 20, 631-638.
52. Cheng,B., Shukla,S., Vasunilashorn,S., Mukhopadhyay,S. and Tse-Dinh,Y.C. (2005) Bacterial cell killing mediated by topoisomerase I DNA cleavage activity. J. Biol. Chem., 280, 38489-38495.
53. Aravind,L., Leipe,D.D. and Koonin,E.V. (1998) Toprim-a conserved catalytic domain in type IA and II topoisomerases, DnaG-type primases, OLD family nucleases and RecR proteins. Nucleic Acids Res., 26 4205-4213.
54. Cheng,B., Sorokin,E.P. and Tse-Dinh,Y.C. (2008) Mutation adjacent to the active site tyrosine can enhance DNA cleavage and cell killing by the TOPRIM gly to ser mutant of bacterial topoisomerase I. Nucleic Acids Res., 36, 1017-1025.
55. Tse-Dinh,Y.C. (1998) Bacterial and archeal type I topoisomerases. Biochim. Biophys. Acta, 1400, 19-27.
56. Zhu,C.X. and Tse-Dinh,Y.C. (2000) The acidic triad conserved in type IA DNA topoisomerases is required for binding of mg(II) and subsequent conformational change. J. Biol. Chem., 275, 5318-5322.
57. Sorokin,E.P., Cheng,B., Rathi,S., Aedo,S.J., Abrenica,M.V. and Tse-Dinh,Y.C. (2008) Inhibition of Mg2+ binding and DNA religation by bacterial topoisomerase I via introduction of an additional positive charge into the active site region. Nucleic Acids Res, 36, 4788-4796.
58. Johnson,A.A., Marchand,C. and Pommier,Y. (2004) HIV-1 integrase inhibitors: A decade of research and two drugs in clinical trial. Curr. Top. Med. Chem., 4, 1059-1077.
59. Pommier,Y., Johnson,A.A. and Marchand,C. (2005) Integrase inhibitors to treat HIV/AIDS. Nat. Rev. Drug Discov., 4, 236-248.
60. Lewinski,M.K. and Bushman,F.D. (2005) Retroviral DNA integration-mechanism and consequences. Adv. Genet., 55, 147-181.
61. Asante-Appiah,E., Seeholzer,S.H. and Skalka,A.M. (1998) Structural determinants of metal-induced conformational changes in HIV-1 integrase. J. Biol. Chem., 273, 35078-35087.
62. Asante-Appiah,E. and Skalka,A.M. (1997) Molecular mechanisms in retrovirus DNA integration. Antiviral Res., 36, 139-156.
63. Grinsztejn,B., Nguyen,B.Y., Katlama,C., Gatell,J.M., Lazzarin,A., Vittecoq,D., Gonzalez,C.J., Chen,J., Harvey,C.M., Isaacs,R.D. et al. (2007) Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: A phase II randomised controlled trial. Lancet, 369, 1261-1269.
64. Steigbigel,R.T., Cooper,D.A., Kumar,P.N., Eron,J.E., Schechter,M., Markowitz,M., Loutfy,M.R., Lennox,J.L., Gatell,J.M., Rockstroh,J.K. et al. (2008) Raltegravir with optimized background therapy for resistant HIV-1 infection. N. Engl. J. Med., 359, 339-354.
65. Sutherland,J.H., Cheng,B., Liu,I.F. and Tse-Dinh,Y.C. (2008) SOS induction by stabilized topoisomerase IA cleavage complex occurs via the RecBCD pathway. J. Bacteriol., 190, 3399-3403.
66. Newmark,K.G., O'Reilly,E.K., Pohlhaus,J.R. and Kreuzer,K.N. (2005) Genetic analysis of the requirements for SOS induction by nalidixic acid in escherichia coli. Gene, 356, 69-76.
67. Malik,M., Zhao,X. and Drlica,K. (2006) Lethal fragmentation of bacterial chromosomes mediated by DNA gyrase and quinolones. Mol. Microbiol. 61, 810-825.
68. Pohlhaus,J.R. and Kreuzer,K.N. (2005) Norfloxacin-induced DNA gyrase cleavage complexes block escherichia coli replication forks, causing double-stranded breaks in vivo. Mol. Microbiol., 56, 1416-1429.
69. Anderson,D.G. and Kowalczykowski,S.C. (1997) The translocating RecBCD enzyme stimulates recombination by directing RecA protein onto ssDNA in a chi-regulated manner. Cell, 90, 77-86.
70. Zhao,X., Malik,M., Chan,N., Drlica-Wagner,A., Wang,J.Y., Li,X. and Drlica,K. (2006) Lethal action of quinolones against a temperature-sensitive dnaB replication mutant of escherichia coli. Antimicrob. Agents Chemother., 50, 362-364.
71. Pouliot,J.J., Yao,K.C., Robertson,C.A. and Nash,H.A. (1999) Yeast gene for a tyr-DNA phosphodiesterase that repairs topoisomerase I complexes. Science, 286, 552-555.
72. Davies,D.R., Interthal,H., Champoux,J.J. and Hol,W.G. (2002) The crystal structure of human tyrosyl-DNA phosphodiesterase, Tdp1. Structure, 10, 237-248.
73. Barthelmes,H.U., Habermeyer,M., Christensen,M.O., Mielke,C., Interthal,H., Pouliot,J.J., Boege,F. and Marko,D. (2004) TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II. J. Biol. Chem., 279, 55618-55625.
74. Nitiss,K.C., Malik,M., He,X., White,S.W. and Nitiss,J.L. (2006) Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage. Proc. Natl Acad. Sci. USA, 103, 8953-8958.
75. Tabary,X., Moreau,N., Dureuil,C. and Le Goffic,F. (1987) Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on escherichia coli topoisomerase I. Antimicrob. Agents Chemother., 31, 1925-1928.
76. Moreau,N.J., Robaux,H., Baron,L. and Tabary,X. (1990) Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II. Antimicrob. Agents Chemother., 34, 1955-1960.
77. Mizushima,T., Natori,S. and Sekimizu,K. (1992) Inhibition of escherichia coli DNA topoisomerase I activity by phospholipids. Biochem. J., 285(pt 2), 503-506.
78. Yigit,H. and Reznikoff,W.S. (1999) Escherichia coli DNA topoisomerase I copurifies with Tn5 transposase, and Tn5 transposase inhibits topoisomerase I. J. Bacteriol., 181, 3185-3192.
79. Weinreich,M.D., Yigit,H. and Reznikoff,W.S. (1994) Overexpression of the Tn5 transposase in escherichia coli results in filamentation, aberrant nucleoid segregation, and cell death: Analysis of E. coli and transposase suppressor mutations. J. Bacteriol., 176, 5494-5504.
80. Yigit,H. and Reznikoff,W.S. (1998) Escherichia coli DNA topoisomerase I and suppression of killing by Tn5 transposase overproduction: Topoisomerase I modulates Tn5 transposition. J. Bacteriol., 180 5866-5874.
81. Cheng,B., Liu,I. and Tse-Dinh,Y.C. (2007) Compounds with antibacterial activity that enhance DNA cleavage by bacterial DNA topoisomerase I. J. Antimicrob. Chemother., 59, 640-645.
82. Makhey,D., Li,D., Zhao,B., Sim,S.P., Li,T.K., Liu,A., Liu,L.F. and LaVoie,E.J. (2003) Substituted benzo[i]phenanthridines as mammalian topoisomerase-targeting agents. Bioorg. Med. Chem., 11, 1809-1820.
83. Chen,A.Y., Yu,C., Gatto,B. and Liu,L.F. (1993) DNA minor groove-binding ligands: A different class of mammalian DNA topoisomerase I inhibitors. Proc. Natl Acad. Sci. USA., 90, 8131-8135.
84. Maxwell,A., Burton,N.P. and O'Hagan,N. (2006) High-throughput assays for DNA gyrase and other topoisomerases. Nucleic Acids Res., 34, e104.
85. Ostrov,D.A., Hernandez Prada,J.A., Corsino,P.E., Finton,K.A., Le,N. and Rowe,T.C. (2007) Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening. Antimicrob. Agents Chemother., 51, 3688-3698.